Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amar J Gajjar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature Reviews. Clinical Oncology|October 29, 2014
Medulloblastoma-translating discoveries from the bench to the bedsideAmar J Gajjar, Giles W Robinson
Nature Reviews. Clinical Oncology|June 29, 2011
Challenging issues in pediatric oncologyChing-Hon Pui, Amar J Gajjar, Javier R Kane, et al.
Journal of Neurosurgery. Pediatrics|September 3, 2011
Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experienceMark Van Poppel, Paul Klimo, Mariko Dewire, et al.
Pediatric Blood & Cancer|September 4, 2023
Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high-risk neuroblastoma clinical trialOlivia Campagne, Huiyun Wu, Jianrong Wu, et al.
Neurosurgery|March 23, 2017
Pineoblastoma-The Experience at St. Jude Children's Research HospitalKara A Parikh, Garrett T Venable, Brent A Orr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate ConstantJessica K Roberts, Anna V Birg, Tong Lin, et al.
Neuro-Oncology|May 26, 2017
Disrupted development and integrity of frontal white matter in patients treated for pediatric medulloblastomaJohn O Glass, Robert J Ogg, Jung W Hyun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumorsNajat C Daw, Victor M Santana, Lisa C Iacono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumorsWayne L Furman, Kristine R Crews, Catherine Billups, et al.
JAMA|October 22, 2002
Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemiaScott C Howard, Amar J Gajjar, Cheng Cheng, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature Reviews. Clinical Oncology|October 29, 2014
Medulloblastoma-translating discoveries from the bench to the bedsideAmar J Gajjar, Giles W Robinson
Nature Reviews. Clinical Oncology|June 29, 2011
Challenging issues in pediatric oncologyChing-Hon Pui, Amar J Gajjar, Javier R Kane, et al.
Journal of Neurosurgery. Pediatrics|September 3, 2011
Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experienceMark Van Poppel, Paul Klimo, Mariko Dewire, et al.
Pediatric Blood & Cancer|September 4, 2023
Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high-risk neuroblastoma clinical trialOlivia Campagne, Huiyun Wu, Jianrong Wu, et al.
Neurosurgery|March 23, 2017
Pineoblastoma-The Experience at St. Jude Children's Research HospitalKara A Parikh, Garrett T Venable, Brent A Orr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate ConstantJessica K Roberts, Anna V Birg, Tong Lin, et al.
Neuro-Oncology|May 26, 2017
Disrupted development and integrity of frontal white matter in patients treated for pediatric medulloblastomaJohn O Glass, Robert J Ogg, Jung W Hyun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumorsNajat C Daw, Victor M Santana, Lisa C Iacono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumorsWayne L Furman, Kristine R Crews, Catherine Billups, et al.
JAMA|October 22, 2002
Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemiaScott C Howard, Amar J Gajjar, Cheng Cheng, et al.
Pageof 2